Series C - New Horizon Health

Series C - New Horizon Health

Investment Firm

Overview

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

Announced Date

May 24, 2019

Closed on Date

May 24, 2019

Funding Type

Series C

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

VMS Asset Management

VMS Asset Management

VMS Asset Management is a debt and private_equity firm.

Participant Investors

9

Investor Name
Participant InvestorMajuven
Participant InvestorAcorn Pacific Ventures
Participant InvestorLegend Capital
Participant InvestorSBCVC
Participant InvestorQiming Venture Partners

Round Details and Background

New Horizon Health raised $66500000 on 2019-05-24 in Series C

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 21, 2020
Series D - New Horizon Health
4-20.0M
Jul 10, 2020
Series E - New Horizon Health
7-30.0M
Mar 01, 2016
Series A - New Horizon Health
2-undefined
Aug 09, 2017
Series B - New Horizon Health
3-20.0M

Recent Activity

There is no recent news or activity for this profile.